AllianceBernstein
HPTX

AllianceBernstein’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

AllianceBernstein’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-6,300
Closed -$289K – 3533
2015
Q1 		$289K Buy
6,300
+3,800
+152% +$114K ﹤0.01% 2692
2014
Q4 		$60K Sell
2,500
-1,200
-32% -$27.1K ﹤0.01% 3080
2014
Q3 		$93K Buy
3,700
+100
+3% +$2.48K ﹤0.01% 2983
2014
Q2 		$94K Buy
3,600
+3,528
+4,900% +$90.7K ﹤0.01% 3010
2014
Q1 		$2K Sell
72
-112,593
-100% -$3.05M ﹤0.01% 3504
2013
Q4 		$2.28M Sell
112,665
-444,982
-80% -$10.5M ﹤0.01% 1616
2013
Q3 		$14.6M Sell
557,647
-204,311
-27% -$5.12M 0.01% 730
2013
Q2 		$16.8M Buy
+761,958
New +$16.7M 0.02% 690

AllianceBernstein's HPTX Position: Q2 2015 in Review

AllianceBernstein sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 6,300 shares — an estimated $289K sold.

AllianceBernstein first reported a position in HPTX in Q2 2013 and held it in 8 quarters. The position peaked at $16.8M in Q2 2013. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • AllianceBernstein reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • AllianceBernstein sold 6,300 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $289K.
  • AllianceBernstein first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • AllianceBernstein's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $16.8M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on AllianceBernstein's 13F filing for Q2 2015, filed 14 Aug 2015.